It has been reported that competitive binding of an IL1 receptor (IL1R) antagonist with the IL1R diminishes basal-fed plasma glucose levels in type 2 diabetic Goto-Kakizaki rats [15]. This evidence concerns the gene IL1R1 and type 2 diabetes mellitus.